Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia

por Wullenkord, Ramona, Reicherts, Christian, Mikesch, Jan-Henrik, Marx, Julia, Wethmar, Klaus, Albring, Jörn, Call, Simon, Lenz, Georg, Stelljes, Matthias
Publicado 2020

PB2413: SALVAGE THERAPY WITH VENETOCLAX AND A HYPOMETHYLATING AGENT FOR PATIENTS WITH AML RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

por Shaforostova, Inna, Marx, Julia, Call, Simon, Peter Floeth, Matthias, Esseling, Eva, Reicherts, Christian, Christian Albring, Joern, Mikesch, Jan-Henrik, Schliemann, Christoph, Lenz, Georg, Stelljes, Matthias
Publicado 2023

Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia

por Wenge, Daniela V., Wethmar, Klaus, Klar, Corinna A., Kolve, Hedwig, Sauer, Tim, Angenendt, Linus, Evers, Georg, Call, Simon, Kerkhoff, Andrea, Khandanpour, Cyrus, Kessler, Torsten, Mesters, Rolf, Schliemann, Christoph, Mikesch, Jan-Henrik, Reicherts, Christian, Brüggemann, Monika, Berdel, Wolfgang E., Lenz, Georg, Stelljes, Matthias
Publicado 2022